Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Iannel Reyes-VidalLaboratorio de Biomedicina Molecular I, Programa de Doctorado en Ciencias en Biotecnología, Escuela Nacional de Medicina y Homeopatía (ENMyH), Instituto Politécnico Nacional, Mexico City 07320, Mexico.ORCID 0000-0001-9106-4103
Ivan Tepale-LedoLaboratorio de Biomedicina Molecular I, Programa de Doctorado en Ciencias en Biotecnología, Escuela Nacional de Medicina y Homeopatía (ENMyH), Instituto Politécnico Nacional, Mexico City 07320, Mexico.ORCID 0000-0001-6564-6919
Gildardo RiveraLaboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa 88710, Mexico.ORCID 0000-0001-9842-4167
Emma Ortiz-IslasLaboratorio de Neurofarmacología Molecular y Nanotecnología, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Mexico City 14269, Mexico.ORCID 0000-0002-3491-0745
Salvador Pérez-MoraLaboratorio de Biomedicina Molecular I, Programa de Doctorado en Ciencias en Biotecnología, Escuela Nacional de Medicina y Homeopatía (ENMyH), Instituto Politécnico Nacional, Mexico City 07320, Mexico.ORCID 0009-0003-0282-9605
David Guillermo Pérez-IshiwaraLaboratorio de Biomedicina Molecular I, Programa de Doctorado en Ciencias en Biotecnología, Escuela Nacional de Medicina y Homeopatía (ENMyH), Instituto Politécnico Nacional, Mexico City 07320, Mexico.ORCID 0000-0001-9368-3717
Yazmin Montserrat Flores-MartinezLaboratorio de Biomedicina Molecular I, Programa de Doctorado en Ciencias en Biotecnología, Escuela Nacional de Medicina y Homeopatía (ENMyH), Instituto Politécnico Nacional, Mexico City 07320, Mexico.ORCID 0000-0001-9382-5316
Maricarmen Lara-RodríguezLaboratorio de Biomedicina Molecular I, Programa de Doctorado en Ciencias en Biotecnología, Escuela Nacional de Medicina y Homeopatía (ENMyH), Instituto Politécnico Nacional, Mexico City 07320, Mexico.ORCID 0000-0003-0379-2296
María Del Consuelo Gómez-GarcíaLaboratorio de Biomedicina Molecular I, Programa de Doctorado en Ciencias en Biotecnología, Escuela Nacional de Medicina y Homeopatía (ENMyH), Instituto Politécnico Nacional, Mexico City 07320, Mexico.ORCID 0000-0002-7888-7700
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
In Silico and In Vitro Evaluation of δ-cadinene from · full record | Socratic